Tulobuterol patch
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- DAE HWA PHARMA
- Publication Date
- 2013-06-05
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The present invention relates to a transdermal absorption preparation comprising tulobuterol (tulobuterol), an anti-asthma drug, as an active ingredient, and in particular relates to a preparation capable of continuously controlling the release of tulobuterol, while having long-term storage stability, and not forming a proper substance in the drug layer. Transdermal formulation of loterol granules. Background technique
[0002] Tulobuterol (chemical formula 1) is a drug used in the treatment of chronic bronchitis and asthma. Currently, tulobuterol is marketed as oral and transdermal formulations. However, transdermal formulations are more preferred because oral formulations often have side effects due to a sudden increase in the blood concentration of tulobuterol.
[0003] [chemical formula 1]
[0004]
[0005] Unlike oral formulations, transdermal formulations avoid the problem of hepatic metabolism and enable sustained delivery of active ingred...